Workers are earning more but still falling behind as the best days of Australia’s jobs boom are firmly in the rear-view mirror.
AstraZeneca and Ionis missed a key heart-drug trial goal, shifting attention to BridgeBio’s approved ATTR-CM treatment.
CFOs are in danger of falling prey to bated-breath predictions of how AI will transform humankind more profoundly than prior ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results